title: Management of hypertension: summary of NICE guidance.
authors.affiliation: National Clinical Guideline Centre Acute and Chronic Conditions, Royal College of Physicians, London, UK.
authors.forename: Taryn
authors.initials: T
authors.lastname: Krause
authors.forename: Kate
authors.initials: K
authors.lastname: Lovibond
authors.forename: Mark
authors.initials: M
authors.lastname: Caulfield
authors.forename: Terry
authors.initials: T
authors.lastname: McCormack
authors.forename: Bryan
authors.initials: B
authors.lastname: Williams
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D057911:Angiotensin Receptor Antagonists / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D044383:Black People; D018660:Blood Pressure Monitoring, Ambulatory; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D006973:Hypertension / Q000175:diagnosis / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D018570:Risk Assessment; D006113:United Kingdom
chemical_list: D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers